1Bone RC, Balk RA, Cerra FB, et al . Definitions for sepsis and organ failure and guidelines for the use of innovation therapies in sepsis. American College of Chest physician/Society of Critical Care Medicine Consensus Conference [J]. Chest , 1992,101(6):1644-1655.
5Vanderschueren S, Weerdt A, Malbrain M, et al. Thromcytopenia and prognosis in intensive care[ J]. Crit Care Med, 2000,28:1871 - 1876.
6Opal SM. Phylogenetic and functional relationships between coagulation and the innate immune response[J] .Crit Care Med,2000,28(9 Suppl) :S77 - S80.
7Hoffman JN, Faist E. Coagulation inhibitor replacement during sepsis:useless[J] ? 2000,28(9 Suppl) : S874 - S876.
8Kessler C，Blood，1997年，89卷，4393页
9Creasey A A，J Clin Invest，1993年，91卷，2850页
10American College of Chest Physician/Society of Critical Care Medicine Consensus:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med,1992,20:864-874.
1American college of chest physican/socienty of critical care medicine consensus, Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J]. Crit Care Med,1992,20:864-874.
2Yaguchi A, Lobo FL. Platelet function in sepsis[J]. Thromb Haemost,2004,2(12) :2096 - 2102.
